KenarJhaveri United States

• Renal Complications of Novel Cancer Therapies: Practical Insights
  AnushreeShirali Speaker
• Immune Checkpoint Inhibitors and AKI
  MitchellRosner Speaker Univeristy of Virginia HealthUnited States
• Electrolyte Abnormalities in the Cancer Patient
  JolantaMalyszko Speaker Medical University of Warsaw, PolandPoland
• Opening an Onconephrology Clinic - What Should You Be Aware of?
  KenarJhaveri Speaker United States
• Q&A

• New Solutions to Anemia Management in Kidney Failure: The Role of HIF-PH Inhibitors
  JolantaMalyszko Speaker Medical University of Warsaw, PolandPoland
• New Solutions to Phosphorus Control in Kidney Failure: Achieving Patient Goals
  KrishnaswamySampathkumar Speaker Meenakshi Mission Hospital India
• Improving Volume and Hypertension Control in Kidney Failure: New Approaches to a Critical Issue?
  Angela Yee-MoonWang Speaker Hong Kong/SingaporeSingapore
• Q and A

• Clinical Trials Overview: Focus on GLP1a, MRA, and SGLT2
  MaartenTaal Speaker University of NottinghamUnited Kingdom
• SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach
  KatherineTuttle Speaker University of Washington School of Medicine, Division of NephrologyUnited States
• SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach
• Q and A

• Approaches to the Patient with Severe Hyponatremia and Acute Kidney Injury
  MitchellRosner Speaker Univeristy of Virginia HealthUnited States
• Approaches to Severe Hypercalcemia
  KenarJhaveri Speaker United States
• Approaches to Severe Hyperkalemia
  KSNayak Speaker Virinchi HospitalsIndia
• Q and A